Combined Treatment of RFA and Sorafenib on Recurrent HCC

NCT01470495 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

430

Enrollment

OTHER

Sponsor class

Conditions

HCC
Radiofrequency Ablation
Sorafenib

Interventions

OTHER: RFA + Sorafenib
OTHER: RFA

Sponsor

Southwest Hospital, China

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]